Improving the quality of life in Arizona to benefit future generations.
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
The Flinn Foundation Seed Grants to Promote Translational Research Program will open its next application cycle on Aug. 1, 2024. The deadline to apply is Sept. 26, 2024.
Each year, the Flinn Foundation funds about 10 research teams affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services addressing significant clinical needs. Program awardees each receive a $100,000 grant over 18 months, plus programmatic benefits. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year. [Learn more]
The growth in Arizona’s bioscience ecosystem continues with new record highs in bioscience jobs and wages, National Institutes of Health funding, university research and development, and certain measures of university technology-transfer—plus an increase in venture capital funding.
The Flinn Foundation hosted its annual Bioscience Progress Report event in April. TEConomy Partners presented the latest performance metrics while a panel discussed the rapid growth of medtech in Arizona. The Progress Report brochure, the most recent data on key metrics, a recording of the event, and more information about Arizona’s Bioscience Roadmap are all now available. [Learn more]
Arizona-based bioscience companies developing blood tests to diagnose cancer and other diseases more quickly and accurately, AI tools to automate lab work, and an alternative way to treat itchiness in dogs have been selected for the 2024 Flinn Foundation Bioscience Entrepreneurship Program.
Four of the six early-stage companies representing the 11th cohort of the program are based in Tucson and two are based in the Phoenix area, including one in Carefree. Each startup will receive $30,000 in non-dilutive funding as well as exclusive opportunities to engage with the state’s bioscience, academic, and policy leaders throughout the year. Since 2014, the Flinn Foundation has selected 66 Arizona bioscience firms in 11 cohorts to participate in the program through a competitive process. [Learn more]
Heather Carter and Jennifer Barton, accomplished Arizona leaders in the biosciences, higher education, and public policy, have been named chair and vice chair of the Arizona’s Bioscience Roadmap Steering Committee.
The committee, administered by the Flinn Foundation, is the statewide leadership group responsible for overseeing the long-term strategic plan to guide the growth and development of the state’s bioscience sector.
Carter, a former legislator, is the senior vice chancellor of external affairs for Maricopa Community Colleges. Barton, a biomedical engineer, researcher, and inventor, is the director of the University of Arizona’s BIO5 Institute in Tucson. [Read more]
Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.
Camacho, an advocate for the biosciences and the arts has served as president and CEO of the economic development organization for nearly a decade. GPEC’s Healthcare Innovation Council supports improvement in population health outcomes, policy that enhances innovation investment, and workforce development. Goodman represents the third generation to lead the Goodmans family business, a furniture and office design company.
Goodman, an ardent supporter of the arts, journalism, and health care, is also a 2023 Arizona Center for Civic Leadership Flinn-Brown Fellow. [Read more]
Bioscience
How redevelopment strategy created a dynamic Downtown Phoenix / AZ Big Media | Bioscience has emerged as a driving force behind Downtown Phoenix’s economic growth. The 30-acre Phoenix Bioscience Core has fostered a thriving ecosystem of innovation and discovery with its research scientists, anchor institutions, proximity to world-class hospitals and now the introduction of the National Institutes of Health.
Bioscience
A doctor for the system / The Lumberjack | Northern Arizona University’s Julie Baldwin is the director of NAU’s Center for Health Equity Research (CHER) and has been in the public health field for more than three decades, where she aims to bring about health equity through social programs and research.
Bioscience
Arizona’s bioscience industry is the 4th-fastest-growing in the nation. Here’s why. / Phoenix Business Journal (Op-ed) |
The momentum is continuing for Arizona’s bioscience industry, fueled by a robust network of premier health care and educational institutions as well as innovators in diagnostics, pharmaceuticals, personalized medicine and genomics, medical devices, cancer treatment, telemedicine, neuroscience and more.
Bioscience
Here’s how much Arizona bioscience sector is outpacing the nation / AZ Big Media | The Arizona bioscience sector has continued its sustained advancement over the past two years and established record highs for several performance metrics, at growth rates often outpacing the nation, according to the latest data analysis commissioned by the Flinn Foundation.